Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 4/20 | 0.37 |
| ▸ | CA12 | O43570 | 3/20 | 0.34 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA9 | Q16790 | 3/20 | 0.34 |
| ▸ | CXCL10 | P02778 | 1/20 | 0.33 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.33 |
| ▸ | CCL2 | P13500 | 1/20 | 0.33 |
| ▸ | CCL5 | P13501 | 1/20 | 0.33 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.33 |
| ▸ | FGF1 | P05230 | 1/20 | 0.33 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28201089 | 1.00 | LGALS3 (0.38) | LGALS3CA2CA12CA1CA9 | |
| SCHEMBL2186684 | 1.00 | LGALS3 (0.38) | LGALS3CA2CA12CA1CA9 | |
| SCHEMBL3914085 | 1.00 | LGALS3 (0.38) | LGALS3CA2CA12CA1CA9 | |
| SCHEMBL7646025 | 0.89 | LGALS8 (0.44) | LGALS3CA2CA12CA1CA9 | |
| SCHEMBL25241935 | 0.88 | CA2 (0.47) | LGALS3CA2CA12CA1CA9 | |
| SCHEMBL3653142 | 0.87 | CA2 (0.40) | LGALS3CA2CA12CA1CA9 | |
| SCHEMBL1116556 | 0.87 | CA2 (0.40) | LGALS3CA2CA12CA1CA9 | |
| SCHEMBL22121795 | 0.87 | CA2 (0.40) | LGALS3CA2CA12CA1CA9 | |
| SCHEMBL8003273 | 0.87 | CA2 (0.40) | LGALS3CA2CA12CA1CA9 | |
| SCHEMBL1116554 | 0.87 | CA2 (0.40) | LGALS3CA2CA12CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026087501-A1 | ANTIGEN MULTIMERS FOR DETECTION OF ANTIGEN-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS | IMMUDEX APS (DK) | 2026-04-30 | — | — | WO | disclosed |
| CN-118987000-A | Application of kappa-carrageenan tetrasaccharide in preparation of medicines or cosmetics | 集美大学 | 2024-11-22 | — | — | CN | disclosed |
| US-20240082276-A1 | LIPID COMPOSITIONS | AKER BIOMARINE HUMAN INGREDIENTS AS (NO) | 2024-03-14 | — | — | US | disclosed |
| CN-115505049-B | Porphyra haitanensis polysaccharide and Porphyra haitanensis polysaccharide effervescent tablet with blood lipid reducing effect and preparation method thereof | 福建农林大学 | 2023-12-08 | — | — | CN | disclosed |
| US-11819509-B2 | Lipid compositions | AKER BIOMARINE ANTARCTIC AS (NO) | 2023-11-21 | — | — | US | disclosed |
| EP-3090729-B1 | EMULSION | VITUX GROUP AS (NO) | 2023-06-07 | — | — | EP | disclosed |
| EP-3008156-B1 | LIPID EXTRACTION PROCESSES | AKER BIOMARINE ANTARCTIC AS (NO) | 2023-06-07 | — | — | EP | disclosed |
| US-11578289-B2 | Lipid extraction processes | AKER BIOMARINE ANTARCTIC AS (NO) | 2023-02-14 | — | — | US | disclosed |
| US-20220409687-A1 | GELLED OIL-IN-WATER EMULSION COMPRISING AT LEAST ONE CANNABINOID | VITUX GROUP AS (NO) | 2022-12-29 | — | — | US | disclosed |
| CN-115505049-A | Porphyra haitanensis polysaccharide and porphyra haitanensis polysaccharide effervescent tablets with blood fat reducing effect and preparation method thereof | 福建农林大学 | 2022-12-23 | — | — | CN | disclosed |
| EP-1115748-B1 | CARRAGEENAN COMPOSITIONS, AND PROCESSES FOR THEIR PRODUCTION | CP KELCO APS (DK) | 2004-10-20 | — | — | EP | disclosed |
| EP-1412336-A1 | PEPTOID COMPOUNDS | UNIVERSITY OF WOLLONGONG (AU) | 2004-04-28 | — | — | EP | disclosed |
| EP-1115850-A4 | MICROBEAD IMMOBILIZATION OF ENZYMES | FMC CORP (US) | 2003-05-21 | — | — | EP | disclosed |
| WO-2003002545-A1 | PEPTOID COMPOUNDS | UNIVERSITY OF WOLLONGONG (AU) | 2003-01-09 | — | — | WO | disclosed |
| US-20020068339-A1 | Microbead immobilization of enzymes | FMC CORPORATION | 2002-06-06 | — | — | US | disclosed |
| US-6268191-B1 | DEHYDRATING HYDROCOLLOID GEL BEADS HAVING A NETWORK STRUCTURE CAPABLE OF SWELLING IN AQUEOUS MEDIA, IMBIBING INTO THE GEL BEADS AN ENZYME IN AN AQEOUS SOLUTION TO FORM IMBIBED GEL BEADS, RECOVER IMBIBED BEADS WITH IMMOBILIZED ENZYME | FMC CORPORATION | 2001-07-31 | — | — | US | disclosed |
| EP-1115850-A1 | MICROBEAD IMMOBILIZATION OF ENZYMES | FMC CORPORATION (US) | 2001-07-18 | — | — | EP | disclosed |
| WO-2000017333-A1 | MICROBEAD IMMOBILIZATION OF ENZYMES | FMC CORPORATION (US) | 2000-03-30 | — | — | WO | disclosed |
| US-5658893-A | Method for inhibition of rotavirus infection with carrageenan | ABBOTT LABORATORIES (US) | 1997-08-19 | — | — | US | disclosed |
| WO-1996030027-A1 | INHIBITION OF ROTAVIRUS INFECTION WITH CARRAGEENAN OR DEXTRAN SULFATE | ABBOTT LABORATORIES (US) | 1996-10-03 | — | — | WO | disclosed |